These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 16645590)
1. The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway. Querfeld C; Rizvi MA; Kuzel TM; Guitart J; Rademaker A; Sabharwal SS; Krett NL; Rosen ST J Invest Dermatol; 2006 Jul; 126(7):1641-7. PubMed ID: 16645590 [TBL] [Abstract][Full Text] [Related]
2. The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Graff JR; McNulty AM; Hanna KR; Konicek BW; Lynch RL; Bailey SN; Banks C; Capen A; Goode R; Lewis JE; Sams L; Huss KL; Campbell RM; Iversen PW; Neubauer BL; Brown TJ; Musib L; Geeganage S; Thornton D Cancer Res; 2005 Aug; 65(16):7462-9. PubMed ID: 16103100 [TBL] [Abstract][Full Text] [Related]
3. Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines. Rizvi MA; Ghias K; Davies KM; Ma C; Weinberg F; Munshi HG; Krett NL; Rosen ST Mol Cancer Ther; 2006 Jul; 5(7):1783-9. PubMed ID: 16891464 [TBL] [Abstract][Full Text] [Related]
4. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells. Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873 [TBL] [Abstract][Full Text] [Related]
5. Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL. Rieger J; Lemke D; Maurer G; Weiler M; Frank B; Tabatabai G; Weller M; Wick W J Neurochem; 2008 Sep; 106(6):2436-48. PubMed ID: 18662322 [TBL] [Abstract][Full Text] [Related]
6. UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines. Shankar SL; Krupski M; Parashar B; Okwuaka C; O'Guin K; Mani S; Shafit-Zagardo B J Neurochem; 2004 Aug; 90(3):702-11. PubMed ID: 15255949 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). Michel L; Dupuy A; Jean-Louis F; Sors A; Poupon J; Viguier M; Musette P; Dubertret L; Degos L; Dombret H; Bachelez H J Invest Dermatol; 2003 Oct; 121(4):881-93. PubMed ID: 14632209 [TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Koh SH; Kim SH; Kwon H; Park Y; Kim KS; Song CW; Kim J; Kim MH; Yu HJ; Henkel JS; Jung HK Brain Res Mol Brain Res; 2003 Oct; 118(1-2):72-81. PubMed ID: 14559356 [TBL] [Abstract][Full Text] [Related]
9. The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. Neri A; Marmiroli S; Tassone P; Lombardi L; Nobili L; Verdelli D; Civallero M; Cosenza M; Bertacchini J; Federico M; De Pol A; Deliliers GL; Sacchi S Leuk Lymphoma; 2008 Jul; 49(7):1374-83. PubMed ID: 18452078 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells. Saba NS; Levy LS J Investig Med; 2012 Jan; 60(1):29-38. PubMed ID: 21997316 [TBL] [Abstract][Full Text] [Related]
11. Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. Civallero M; Cosenza M; Grisendi G; Marcheselli L; Todoerti K; Sacchi S Leuk Lymphoma; 2010 Apr; 51(4):671-9. PubMed ID: 20218811 [TBL] [Abstract][Full Text] [Related]
12. Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Jian W; Yamashita H; Levitt JM; Lerner SP; Sonpavde G Mol Cancer Ther; 2009 Jul; 8(7):1772-8. PubMed ID: 19509273 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of apoptosis induction in skin cancer cells by the centipedegrass extract. Badaboina S; Bai HW; Park CH; Jang DM; Choi BY; Chung BY BMC Complement Altern Med; 2013 Dec; 13():350. PubMed ID: 24325618 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia. Moreau AS; Jia X; Ngo HT; Leleu X; O'Sullivan G; Alsayed Y; Leontovich A; Podar K; Kutok J; Daley J; Lazo-Kallanian S; Hatjiharissi E; Raab MS; Xu L; Treon SP; Hideshima T; Anderson KC; Ghobrial IM Blood; 2007 Jun; 109(11):4964-72. PubMed ID: 17284528 [TBL] [Abstract][Full Text] [Related]
15. The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. Wu X; Zhu M; Fletcher JA; Giobbie-Hurder A; Hodi FS PLoS One; 2012; 7(1):e29622. PubMed ID: 22253748 [TBL] [Abstract][Full Text] [Related]
16. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene. Koh SH; Lee YB; Kim KS; Kim HJ; Kim M; Lee YJ; Kim J; Lee KW; Kim SH Eur J Neurosci; 2005 Jul; 22(2):301-9. PubMed ID: 16045483 [TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 1-dependent dephosphorylation of Akt is the prime signaling event in sphingosine-induced apoptosis in Jurkat cells. Thayyullathil F; Chathoth S; Shahin A; Kizhakkayil J; Hago A; Patel M; Galadari S J Cell Biochem; 2011 Apr; 112(4):1138-53. PubMed ID: 21308747 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of Sorafenib and Sunitinib with Enzastaurin, a selective protein kinase C inhibitor in renal cell carcinoma cell lines. Vogl UM; Berger W; Micksche M; Pirker C; Lamm W; Pichelmeyer O; Zielinski CC; Schmidinger M Cancer Lett; 2009 May; 277(2):218-26. PubMed ID: 19171421 [TBL] [Abstract][Full Text] [Related]
19. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways. Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592 [TBL] [Abstract][Full Text] [Related]
20. Modulation of curcumin-induced Akt phosphorylation and apoptosis by PI3K inhibitor in MCF-7 cells. Kizhakkayil J; Thayyullathil F; Chathoth S; Hago A; Patel M; Galadari S Biochem Biophys Res Commun; 2010 Apr; 394(3):476-81. PubMed ID: 20138829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]